Senores Pharmaceuticals shares debut with 53.5% gains, listing at Rs 600 on NSE

Senores Pharmaceuticals made its stock market debut today, December 30, 2024, on the NSE at Rs 600, delivering a 53.45% premium over its issue price of Rs 391. While the listing gains are significant, they fall slightly short of the expectations based on the Grey Market Premium (GMP), which suggested a 72.63% listing premium.

Key Listing Details:

Advertisement

  • Issue Price: ₹391
  • Listing Price (NSE): ₹600
  • Listing Gain: 53.45%
  • Retail Lot Profit: ₹7,942

IPO Highlights:

  • Price Band: ₹372 – ₹391 per share
  • Lot Size: 38 shares
  • IPO Size: ₹582.11 crore (Fresh Issue: ₹500 crore, OFS: 21,00,000 shares)
  • Subscription Rates:
    • QIBs: 94.66 times
    • NIIs: 96.11 times
    • Retail: 89.23 times
    • Employees: 19.92 times

Grey Market Premium (GMP):

Ahead of the listing, the IPO commanded a GMP of ₹284, indicating a potential listing price of ₹675. However, the actual listing at Rs 600 reflected slightly lower demand in the secondary market.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.